A Proof of Concept Study in Patients Suffering of Knee Osteoarthritis (OA) and Receiving Intra-articular (IA) Injection of Synvisc-one® to Assess the Clinical Pertinence of a New Analytical Tool of Synovial Fluid
The objective of this trial is to assess the clinical pertinence of an innovative analytical tool (SYNODIAG) to analyze the Synovial Fluid (SF) composition and guide the patient treatment in a Proof of Concept (PoC) study using OA patients receiving IA injection of SYNVISC ONE®.
100 项与 Pulsalys SAS 相关的临床结果
0 项与 Pulsalys SAS 相关的专利(医药)
100 项与 Pulsalys SAS 相关的药物交易
100 项与 Pulsalys SAS 相关的转化医学